Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis

BACKGROUND: The presence of anti-HER2 agents, such as trastuzumab, pertuzumab, and trastuzumab emtansine (T-DM1), significantly improved the prognosis of metastatic HER2-positive (HER2+) breast cancers (BC). However, drug resistance and disease progression are still common. In order to further impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaohui, Leng, Junsheng, Zhou, Yidong, Mao, Feng, Lin, Yan, Shen, Songjie, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416996/
https://www.ncbi.nlm.nih.gov/pubmed/34490125
http://dx.doi.org/10.3389/fonc.2021.731210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416996/
https://www.ncbi.nlm.nih.gov/pubmed/34490125
http://dx.doi.org/10.3389/fonc.2021.731210

Ejemplares similares